Former GOP leader Eric Cantor appointed to steer PhRMA amid bipartisan concerns over drug costs
Eric Cantor, former House Republican leader, has been tapped to lead the Pharmaceutical Research and Manufacturers of America (PhRMA) in its Washington lobbying efforts.
Cantor previously tried to reposition the GOP away from a perception of serving only the wealthy and corporate interests, a strategy highlighted in a 2013 New Yorker profile.
His new role comes as lawmakers from both parties criticize rising health‑care costs, putting pressure on the industry to address pricing concerns.
Observers will watch whether Cantor’s political experience can help PhRMA navigate the current bipartisan backlash and shape policy outcomes.
This writeup was produced by pharmadog from original reporting by STAT.
Original headline: “STAT+: Can a top Republican from a bygone political era fix pharma’s woes in Washington?”
read at STAT ↗
comments(0)
5-min edit window · permanent after that